calpastatin has been researched along with Malaria--Falciparum* in 2 studies
2 other study(ies) available for calpastatin and Malaria--Falciparum
Article | Year |
---|---|
Cerebral calpain in fatal falciparum malaria.
Disruption of axonal transport may represent a final common pathway leading to neurological dysfunction in cerebral malaria (CM). Calpains are calcium (Ca2+)-activated cysteine proteases which have been implicated in axonal injury in neurological diseases of various aetiologies. In this study we examined the association between mu- and m-calpain, the specific inhibitor calpastatin, and axonal injury in post mortem brain tissue from patients who died from severe malaria. Calpains were associated with axons labelled for the beta-amyloid precursor protein that detects impaired axonal transport. Elevated levels of calpastatin were rarely observed in injured axons. There were increased numbers of neurones with mu-calpain in the nuclear compartment in severe malaria cases compared with non-neurological controls, and increased numbers of glia with nuclear mu-calpain in CM patients compared with non-CM malaria cases and non-neurological controls. There was marked redistribution of calpastatin in the sequestered Plasmodium falciparum-infected erythrocytes. Responses specific to malaria infection were ascertained following analysis of brain samples from fatal cases with acute axonal injury, HIV encephalitis, and progressive multifocal leucoencephalopathy. Our findings implicate a role for calpains in the modulation of disease progression in CM. Topics: Adult; Aged; AIDS Dementia Complex; Axonal Transport; Axons; Calcium-Binding Proteins; Calpain; Endothelium, Vascular; Erythrocytes; Female; Humans; Immunohistochemistry; Leukoencephalopathy, Progressive Multifocal; Malaria, Falciparum; Male; Middle Aged; Neuroglia; Neurons | 2007 |
PEST sequences in the malaria parasite Plasmodium falciparum: a genomic study.
Inhibitors of the protease calpain are known to have selectively toxic effects on Plasmodium falciparum. The enzyme has a natural inhibitor calpastatin and in eukaryotes is responsible for turnover of proteins containing short sequences enriched in certain amino acids (PEST sequences). The genome of P. falciparum was searched for this protease, its natural inhibitor and putative substrates.. The publicly available P. falciparum genome was found to have too many errors to permit reliable analysis. An earlier annotation of chromosome 2 was instead examined. PEST scores were determined for all annotated proteins. The published genome was searched for calpain and calpastatin homologs.. Typical PEST sequences were found in 13% of the proteins on chromosome 2, including a surprising number of cell-surface proteins. The annotated calpain gene has a non-biological "intron" that appears to have been created to avoid an unrecognized frameshift. Only the catalytic domain has significant similarity with the vertebrate calpains. No calpastatin homologs were found in the published annotation.. A calpain gene is present in the genome and many putative substrates of this enzyme have been found. Calpastatin homologs may be found once the re-annotation is completed. Given the selective toxicity of calpain inhibitors, this enzyme may be worth exploring further as a potential drug target. Topics: Amino Acid Sequence; Animals; Calcium-Binding Proteins; Calpain; Cysteine Proteinase Inhibitors; Databases, Genetic; Genome, Protozoan; Malaria, Falciparum; Plasmodium falciparum; Protozoan Proteins | 2003 |